NVCR
NovoCure Limited
NASDAQ · Healthcare · Medical - Instruments & Supplies · JE
$17.90
+1.46%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2.78x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 6.16x
- Price / sales
- 2.98x
- Price / cash flow
- 1395.02x
Enterprise value
- Enterprise value
- $1.9B
- EV / sales
- 2.68x
- EV / EBITDA
- -13.97x
- EV / EBIT
- -12.16x
- Market cap
- $2.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026